In comparison to contrast-enhanced CT, FAPI PET was associated with over 27 percent higher sensitivity for peritoneal carcinomatosis in the small bowel and 53 percent higher sensitivity in the upper abdomen, according to a new study involving 200 women with primary ovarian carcinoma.
New research suggests that photon-counting CT provides comparable sensitivity to breast MRI for lesion characterization, higher accuracy than MRI for nodal metastasis and lower detection of microcalcifications in comparison to full-field digital mammography.
Elevated coronary inflammation, measured with the CCTA-derived and AI-enabled perivascular fat attenuation index (FAI) score, was associated with over a 12-fold higher risk for cardiovascular mortality in patients with no diabetes, hypertension, smoking history or obesity, according to new research presented at the European Society of Cardiology (ESC) Congress.
In a recent episode of our Molecular Imaging in Focus series, Sharmila Dorbala, MD, MPH, discusses phase 3 study findings on the use of the PET/CT radiotracer 124I- evuzamatide for overall detection of cardiac amyloidosis as well as the subtypes light-chain amyloidosis (AL) and transthyretin amyloidosis (ATTR) cardiac amyloidosis.
To what degree does your work setting and employer preferences affect your accuracy and approach to defensive medicine?
New research presented at the European Society of Cardiology (ESC) conference demonstrates that fractional flow reserve (FFR) based off CCTA exams significantly decreases unnecessary invasive coronary angiography (ICA) procedures for patients with stable chest pain and obstructive stenosis.
In a recent interview, Arun Talkad, MD, discussed the use of AI-powered enterprise imaging to facilitate recently expanded acute stroke care guidelines from the American Heart Association and the American Stroke Association.
Catch up on the most-well viewed radiology content in August 2026.
This summer's breast imaging research spanned digital breast tomosynthesis (DBT) efficiency gains, AI models that flag cancer risk years before diagnosis, a cautionary study on automation bias, and advances in ultrasound, MRI, and contrast-enhanced mammography (CEM). Here is a look back at the most well-viewed breast imaging content of the summer.
Catch up on the top AI-related news and research in radiology over the past month.
Having perspective on what constitutes bad luck, human error or a legitimate beef can prevent a lot of wasted energy on negativity inside and outside of the reading room.
Catch up on the top radiology content of the past week.
Catch up on a variety of FDA news in radiology from the past week.
In addition to providing stronger image quality, well-designed photon-counting CT systems may facilitate increased standardization, efficiency and simplification that may lead to reduced cognitive burden for radiologists.
Reducing false positives in evaluation of muscle invasion in bladder cancer cases that can occur with conventional imaging, spectral information with photon-counting CT may offer significantly improved accuracy and specificity in local staging.
In the latest episode of his “Interventional Radiology in Focus” series, Mina Makary, MD, discusses the appeal of the specialty, key advances in the field in recent years, and the need for increased awareness of what interventional radiology can offer to patients.
The AI-powered software NeuroQuant PET reportedly offers automated quantification and structured reporting and facilitates evaluation of brain scans with multiple amyloid PET radiotracers.
Preliminary research with the PET radiopharmaceutical 68Ga-NYM096 has demonstrated a 95.7 percent accuracy rate in patients with primary clear cell renal cell carcinoma (ccRCC) and a significantly higher mean SUVmax in the most active lesions in comparison to 18F-FDG.
For patients who had successful reperfusion after acute ischemic stroke, new research demonstrated an 80 percent AUC for predicting infarct with the combination of apparent diffusion coefficient (ADC) mapping and relative oxygen ejection fraction (rOEF).
In a recent Practice Academy webinar session, Nina Kottler, MD, MS, FSIIM, FAIM, discussed challenges with narrow AI applications, the continued emergence of foundation models and a potential trajectory with AI that may facilitate a combination of opportunistic screening and prognostic risk assessment.
In a recent Practice Academy webinar session, Seena Dehkharghani, MD, FAHA, and Raza Mushtaq, MD, discussed the challenge of burgeoning worklist volume amid the ongoing radiologist shortage and the emergence of AI advances with enterprise imaging.
The cmAngio 2.0 AI-enabled software reportedly offers new capabilities for quantitative measurement of breast arterial calcification (BAC) as well as age-based contextualization based on mammography assessment.
New research revealed that risk-stratified MRI surveillance in patients with cirrhosis led to over a 10 percent increase in early detection and over a 44 percent decrease in surveillance exams in comparison to reported results with semiannual ultrasound monitoring.
While maintenance of certification requires participation in peer review, a collegial ethos enables us to provide assessment of another radiologist’s work without crossing the line into odious expert witness cash grabs.
Catch up on the latest contrast-enhanced mammography research, CT insights, MRI studies and FDA approvals in PET imaging with our Weekly Scan.
Recent positron emission tomography (PET) studies with florquinitau F 18 injection (Tauklarify) demonstrated inter-reader agreement ranging between 86 to 92 percent in evaluating patients for Alzheimer’s disease.
The high-resolution temporal and spatial imaging with photon-counting CT bolster our understanding of the connections between anatomy and function in structural heart imaging.
Use of the CARE Multi-Triage CT Body software will be eligible for a New Technology Add-on Payment (NTAP) from CMS starting on October 1, 2026 for inpatients in Medicare fee for service plans.
In the latest episode of her “Breast Imaging in Focus” series, Manisha Bahl, MD, MPH, FSBI, offers her perspective on a new study that examines the effectiveness of contrast-enhanced mammography in initial and subsequent rounds of breast cancer screening.
In a recent episode of our “Molecular Imaging in Focus” series, Martin Pomper, MD, PhD, discussed the origin of PSMA PET, shared his perspective on non-PSMA targets in prostate cancer and offered his thoughts on the potential promise of emerging theranostics.
